SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsArchive2026-11-12

Thu, Nov 12, 2026 - Page 65

13819 indexed SquawkNews stories from this UTC day. Showing 7681-7800.

EQUITY 5982EARNINGS 4842FX 653NEWS 460CENTRAL_BANK 417MACRO 293GEOPOLITICS 273REGULATION 219MNA 175RATES 149ENERGY 148COMMODITIES 145
M Kraft Heinz Sees FY2027 Adjusted Operating Income Declining Low Single Digits The company expects adjusted operating income to decline by low single digits versus 2026, with a return to growth in the second half of 2027. EARNINGS | Nov 12, 2026, 12:30 PM UTC L ALTIMMUNE Q3 EPS USD -0.15 VS. IBES ESTIMATE USD -0.14 ALTIMMUNE Q3 EPS USD -0.15 VS. IBES ESTIMATE USD -0.14 EARNINGS | Nov 12, 2026, 12:30 PM UTC L SUBURBAN PROPANE PARTNERS Q4 REVENUE USD 219.864 MILLION SUBURBAN PROPANE PARTNERS Q4 REVENUE USD 219.864 MILLION EARNINGS | Nov 12, 2026, 12:30 PM UTC L TAYSHA GENE THERAPIES Q3 EPS USD -0.1 TAYSHA GENE THERAPIES Q3 EPS USD -0.1 EARNINGS | Nov 12, 2026, 12:30 PM UTC L SOLO BRANDS Q3 GROSS PROFIT USD 27.716 MILLION SOLO BRANDS Q3 GROSS PROFIT USD 27.716 MILLION EARNINGS | Nov 12, 2026, 12:30 PM UTC L SOLO BRANDS Q3 ADJUSTED EPS USD -4.51 SOLO BRANDS Q3 ADJUSTED EPS USD -4.51 EARNINGS | Nov 12, 2026, 12:30 PM UTC L Cormedix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update Recently announced acquisition of assets of Heron Therapeutics — — Q3 2026 consolidated revenue of EARNINGS | Nov 12, 2026, 12:30 PM UTC L CORMEDIX THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE CORMEDIX THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE EQUITY | Nov 12, 2026, 12:30 PM UTC L TAYSHA GENE THERAPIES REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE TAYSHA GENE THERAPIES REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE EQUITY | Nov 12, 2026, 12:30 PM UTC L SOLO BRANDS Q3 NET INCOME USD -20.754 MILLION SOLO BRANDS Q3 NET INCOME USD -20.754 MILLION FX | Nov 12, 2026, 12:30 PM UTC L Cormedix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update Cormedix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update — Re EQUITY | Nov 12, 2026, 12:30 PM UTC L Boost Run (BRUN) Q3 Revenue Reaches $39.9M, Up Approximately 496% YoY Boost Run reported Q3 2026 revenue of $39.9M, approximately 496% higher year over year. It reported $157M in unrestricted cash at quarter-end and $2.7B in total contract value.Material DetailsContext by AI AnalystThis is EARNINGS | Nov 12, 2026, 12:30 PM UTC L SUBURBAN PROPANE PARTNERS Q4 PRETAX PROFIT USD -55.106 MILLION SUBURBAN PROPANE PARTNERS Q4 PRETAX PROFIT USD -55.106 MILLION EARNINGS | Nov 12, 2026, 12:30 PM UTC L CORMEDIX Q3 EPS USD -0.19 VS. IBES ESTIMATE USD -0.12 CORMEDIX Q3 EPS USD -0.19 VS. IBES ESTIMATE USD -0.12 EARNINGS | Nov 12, 2026, 12:30 PM UTC L TAYSHA GENE THERAPIES Q3 OPERATING INCOME USD -41.872 MILLION TAYSHA GENE THERAPIES Q3 OPERATING INCOME USD -41.872 MILLION FX | Nov 12, 2026, 12:30 PM UTC L Treaty Creek Drill Intersects 9.00 g/t Gold Over 9.50 Metres Teuton Resources reports drilling at the Treaty Creek property intersected 9.00 g/t gold over 9.50 metres, including 43.29 g/t over 1.20 metres. COMMODITIES | Nov 12, 2026, 12:30 PM UTC L Nexxen International 3Q EPS 32c >NEXN Nexxen International 3Q EPS 32c >NEXN EARNINGS | Nov 12, 2026, 12:30 PM UTC L Creative Realities Signs Exclusive Agreement With Toyota/Lexus Canada Creative Realities announced an exclusive agreement with Toyota/Lexus Canada to power the dealership digital experience. EQUITY | Nov 12, 2026, 12:30 PM UTC L Altimmune Announces Third Quarter 2026 Financial Results and Business Update Altimmune Announces Third Quarter 2026 Financial Results and Business Update Global PERFORMA Phase 3 EQUITY | Nov 12, 2026, 12:30 PM UTC L NEUPATH HEALTH Q3 ADJUSTED EBITDA CAD 200 THOUSAND NEUPATH HEALTH Q3 ADJUSTED EBITDA CAD 200 THOUSAND FX | Nov 12, 2026, 12:30 PM UTC L NeuPath Health Inc. (NPTH) Q3 Revenue Rises 1% to $22.3M; Adjusted EBITDA Falls to $1.4M Q3 2026 revenue was $22.3M versus $22.1M a year earlier; Adjusted EBITDA was $1.4M versus $1.5M. Nine-month revenue was $67.1M versus $65.0M, including a $1.9M prior-year one-time payment; excluding it, prior-year revenu EARNINGS | Nov 12, 2026, 12:30 PM UTC L ALTIMMUNE ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS AND BUSINESS UPDATE ALTIMMUNE ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS AND BUSINESS UPDATE EQUITY | Nov 12, 2026, 12:30 PM UTC L Taysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update Taysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update REV EQUITY | Nov 12, 2026, 12:30 PM UTC L SOLO BRANDS, INC. ANNOUNCES FISCAL 2026 THIRD QUARTER RESULTS SOLO BRANDS, INC. ANNOUNCES FISCAL 2026 THIRD QUARTER RESULTS EQUITY | Nov 12, 2026, 12:30 PM UTC L Nexxen International 3Q Rev $102.9M >NEXN Nexxen International 3Q Rev $102.9M >NEXN EQUITY | Nov 12, 2026, 12:30 PM UTC L SUBURBAN PROPANE PARTNERS, L.P. ANNOUNCES FULL YEAR AND FOURTH QUARTER RESULTS SUBURBAN PROPANE PARTNERS, L.P. ANNOUNCES FULL YEAR AND FOURTH QUARTER RESULTS EQUITY | Nov 12, 2026, 12:30 PM UTC L AVICANNA REPORTS POSITIVE ADJUSTED EBITDA FOR Q3 2026 AND PROVIDES CORPORATE UPDATE AVICANNA REPORTS POSITIVE ADJUSTED EBITDA FOR Q3 2026 AND PROVIDES CORPORATE UPDATE EQUITY | Nov 12, 2026, 12:30 PM UTC L BASE CARBON REPORTS THIRD-QUARTER 2026 OPERATING AND FINANCIAL RESULTS BASE CARBON REPORTS THIRD-QUARTER 2026 OPERATING AND FINANCIAL RESULTS EQUITY | Nov 12, 2026, 12:30 PM UTC L ASCENDIS PHARMA REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS ASCENDIS PHARMA REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS EQUITY | Nov 12, 2026, 12:30 PM UTC L MediPharm Labs Reports Q3 2026 Results with Second Consecutive Quarter of Positive Net Income and 18% Sequential Revenue Growth Net Income was positive for the second consecutive quarter, and Adjusted EBITDA1 positive for its th EARNINGS | Nov 12, 2026, 12:30 PM UTC L Nexxen Reports Record Third Quarter 2026 Financial Results Nexxen Reports Record Third Quarter 2026 Financial Results Delivered record Q3 Contribution ex-TAC a EQUITY | Nov 12, 2026, 12:30 PM UTC L ALTIMMUNE Q3 BASIC EPS USD -0.15 ALTIMMUNE Q3 BASIC EPS USD -0.15 EARNINGS | Nov 12, 2026, 12:30 PM UTC L SUBURBAN PROPANE PARTNERS Q4 OPERATING INCOME USD -12.909 MILLION SUBURBAN PROPANE PARTNERS Q4 OPERATING INCOME USD -12.909 MILLION FX | Nov 12, 2026, 12:30 PM UTC L Ascendis Pharma Reports Third Quarter 2026 Financial Results Ascendis Pharma Reports Third Quarter 2026 Financial Results Q3 2026 product revenue of €366 million EARNINGS | Nov 12, 2026, 12:30 PM UTC M Boost Run Reports Third-Quarter 2026 Results Boost Run reported third-quarter results, highlighting $2.7 billion in total contract value and 496% year-over-year revenue growth. EQUITY | Nov 12, 2026, 12:30 PM UTC L ALTIMMUNE Q3 NET INCOME USD -31.608 MILLION VS. IBES ESTIMATE USD -25.5 MILLION ALTIMMUNE Q3 NET INCOME USD -31.608 MILLION VS. IBES ESTIMATE USD -25.5 MILLION FX | Nov 12, 2026, 12:30 PM UTC L SUBURBAN PROPANE PARTNERS Q4 NET INCOME USD -56.841 MILLION SUBURBAN PROPANE PARTNERS Q4 NET INCOME USD -56.841 MILLION FX | Nov 12, 2026, 12:30 PM UTC L NEXXEN REPORTS RECORD THIRD QUARTER 2026 FINANCIAL RESULTS NEXXEN REPORTS RECORD THIRD QUARTER 2026 FINANCIAL RESULTS EQUITY | Nov 12, 2026, 12:30 PM UTC L BRIDGEMARQ Q3 NET INCOME CAD 66.9 MILLION BRIDGEMARQ Q3 NET INCOME CAD 66.9 MILLION FX | Nov 12, 2026, 12:30 PM UTC L Creative Realities Signs Exclusive Agreement With Toyota and Lexus Canada Creative Realities signed an exclusive agreement with Toyota and Lexus Canada to power the dealership digital experience. EQUITY | Nov 12, 2026, 12:30 PM UTC L AVICANNA Q3 REVENUE CAD 5.73 MILLION AVICANNA Q3 REVENUE CAD 5.73 MILLION EARNINGS | Nov 12, 2026, 12:30 PM UTC L BRIDGEMARQ Q3 EPS CAD 0.04 BRIDGEMARQ Q3 EPS CAD 0.04 EARNINGS | Nov 12, 2026, 12:30 PM UTC L Suburban Propane Partners, L.P. Announces Full Year and Fourth Quarter Results WHIPPANY, N.J., Nov. 12, 2026 /PRNewswire/ -- Suburban Propane Partners, L.P. EQUITY | Nov 12, 2026, 12:30 PM UTC L Solo Brands, Inc. Announces Fiscal 2026 Third Quarter Results Solo Brands, Inc. Announces Fiscal 2026 Third Quarter Results Positive Operating Cash Flow and Impro EQUITY | Nov 12, 2026, 12:30 PM UTC L BRIDGEMARQ REAL ESTATE SERVICES® REPORTS THIRD QUARTER FINANCIAL RESULTS BRIDGEMARQ REAL ESTATE SERVICES® REPORTS THIRD QUARTER FINANCIAL RESULTS EQUITY | Nov 12, 2026, 12:30 PM UTC L MEDIPHARM LABS Q3 REVENUE CAD 11.8 MILLION MEDIPHARM LABS Q3 REVENUE CAD 11.8 MILLION EARNINGS | Nov 12, 2026, 12:30 PM UTC L MEDIPHARM LABS Q3 ADJUSTED EBITDA CAD 400 THOUSAND MEDIPHARM LABS Q3 ADJUSTED EBITDA CAD 400 THOUSAND FX | Nov 12, 2026, 12:30 PM UTC L MEDIPHARM LABS Q3 GROSS PROFIT CAD 3.8 MILLION MEDIPHARM LABS Q3 GROSS PROFIT CAD 3.8 MILLION EARNINGS | Nov 12, 2026, 12:30 PM UTC L CorMedix 3Q Loss/Shr 19c >CRMD CorMedix 3Q Loss/Shr 19c >CRMD EQUITY | Nov 12, 2026, 12:30 PM UTC L SAGIMET BIOSCIENCES REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATES SAGIMET BIOSCIENCES REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATES EQUITY | Nov 12, 2026, 12:30 PM UTC L Ascendis Pharma Reports Third Quarter 2026 Financial Results Q3 2026 product revenue of €366 million (+89% Y/Y), comprising €291 million for YORVIPATH®, €59 mill EARNINGS | Nov 12, 2026, 12:30 PM UTC L NEUPATH HEALTH REPORTS THIRD QUARTER 2026 RESULTS NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), which operates one of Canada’s largest networks of community-based, multidisciplinary medical facilities focused on the assessment and treatment of chronic p EQUITY | Nov 12, 2026, 12:30 PM UTC L BOOST RUN INC. REPORTS THIRD QUARTER 2026 RESULTS, HIGHLIGHTING $2.7 BILLION IN TOTAL CONTRACT VALUE AND 496% YEAR-OVER-YEAR REVENUE GROWTH BOOST RUN INC. REPORTS THIRD QUARTER 2026 RESULTS, HIGHLIGHTING $2.7 BILLION IN TOTAL CONTRACT VALUE EARNINGS | Nov 12, 2026, 12:30 PM UTC L BRIDGEMARQ Q3 OPERATING CASH FLOW CAD 6.012 MILLION BRIDGEMARQ Q3 OPERATING CASH FLOW CAD 6.012 MILLION FX | Nov 12, 2026, 12:30 PM UTC L BRIDGEMARQ Q3 REVENUE CAD 107.728 MILLION BRIDGEMARQ Q3 REVENUE CAD 107.728 MILLION EARNINGS | Nov 12, 2026, 12:30 PM UTC L NEUPATH HEALTH Q3 REVENUE CAD 22.3 MILLION NEUPATH HEALTH Q3 REVENUE CAD 22.3 MILLION EARNINGS | Nov 12, 2026, 12:30 PM UTC L MEDIPHARM LABS REPORTS Q3 2026 RESULTS WITH SECOND CONSECUTIVE QUARTER OF POSITIVE NET INCOME AND 18% SEQUENTIAL REVENUE GROWTH MEDIPHARM LABS REPORTS Q3 2026 RESULTS WITH SECOND CONSECUTIVE QUARTER OF POSITIVE NET INCOME AND 18 EARNINGS | Nov 12, 2026, 12:30 PM UTC L Base Carbon Reports Third-Quarter 2026 Operating and Financial Results Base Carbon Reports Third-Quarter 2026 Operating and Financial Results TORONTO, Nov. 12, 2026 (GLOBE EQUITY | Nov 12, 2026, 12:30 PM UTC L NEUPATH HEALTH REPORTS THIRD QUARTER 2026 RESULTS NEUPATH HEALTH REPORTS THIRD QUARTER 2026 RESULTS EQUITY | Nov 12, 2026, 12:30 PM UTC L Taysha Gene Therapies 3Q Loss/Shr 10c >TSHA Taysha Gene Therapies 3Q Loss/Shr 10c >TSHA EQUITY | Nov 12, 2026, 12:30 PM UTC L MediPharm Labs Reports Q3 2026 Results with Second Consecutive Quarter of Positive Net Income and 18% Sequential Revenue Growth MediPharm Labs Reports Q3 2026 Results with Second Consecutive Quarter of Positive Net Income and 18 EARNINGS | Nov 12, 2026, 12:30 PM UTC L Taysha Gene Therapies 3Q Loss $39.1M >TSHA Taysha Gene Therapies 3Q Loss $39.1M >TSHA EQUITY | Nov 12, 2026, 12:30 PM UTC L SAGIMET BIOSCIENCES Q3 NET INCOME USD -19.149 MILLION SAGIMET BIOSCIENCES Q3 NET INCOME USD -19.149 MILLION FX | Nov 12, 2026, 12:30 PM UTC L Avicanna Reports Positive Adjusted EBITDA for Q3 2026 and Provides Corporate Update Avicanna Reports Positive Adjusted EBITDA for Q3 2026 and Provides Corporate Update Adjusted EBITDA EQUITY | Nov 12, 2026, 12:30 PM UTC M European session market picture: S&P 500 -0.38%, Nasdaq 100 -0.86%; EUR/USD +0.01%, WTI -0.86%, LLOY leads volume European session market picture. US index futures: S and P futures is down 0.38 percent, Nasdaq futures is down 0.86 percent, Dow futures is up 0.11 percent and Russell futures is down 0.08 percent. In currencies, the do EQUITY | Nov 12, 2026, 12:30 PM UTC L NEUPATH HEALTH REPORTS THIRD QUARTER 2026 RESULTS Third quarter total revenue of $22.3 million Positive cash flows from operations, with Adjusted EBIT EARNINGS | Nov 12, 2026, 12:30 PM UTC L Altimmune 3Q Loss/Shr 15c >ALT Altimmune 3Q Loss/Shr 15c >ALT EQUITY | Nov 12, 2026, 12:30 PM UTC L Boost Run Inc. Reports Third Quarter 2026 Results, Highlighting $2.7 Billion in Total Contract Value and 496% Year-Over-Year Revenue Growth NORTHBROOK, Ill.--(BUSINESS WIRE)-- Boost Run, Inc. (Nasdaq: BRUN), an NVIDIA Preferred Cloud Partne EARNINGS | Nov 12, 2026, 12:30 PM UTC L Suburban Propane 4Q Rev $219.9M >SPH Suburban Propane 4Q Rev $219.9M >SPH EQUITY | Nov 12, 2026, 12:30 PM UTC L Suburban Propane 4Q Loss $56.8M >SPH Suburban Propane 4Q Loss $56.8M >SPH EQUITY | Nov 12, 2026, 12:30 PM UTC H *--Earnings Flash (GENB) Generate Biomedicines Posts Q3 Net Loss $0.68 a Share, vs. FactSet Est of $0.56 Loss *--Earnings Flash (GENB) Generate Biomedicines Posts Q3 Net Loss $0.68 a Share, vs. FactSet Est of $0.56 Loss EARNINGS | Nov 12, 2026, 12:30 PM UTC L Nexxen Reports Record Third Quarter 2026 Financial Results Delivered record Q3 Contribution ex-TAC and programmatic revenue, highlighted by continued enterpris EARNINGS | Nov 12, 2026, 12:30 PM UTC L Suburban Propane 4Q Loss/Shr 85c >SPH Suburban Propane 4Q Loss/Shr 85c >SPH EQUITY | Nov 12, 2026, 12:30 PM UTC L Creative Realities Signs Exclusive Toyota/Lexus Canada Dealership Agreement EQUITY | Nov 12, 2026, 12:30 PM UTC L Bridgemarq Real Estate Services® Reports Third Quarter Financial Results TORONTO, Nov. 12, 2026 /CNW/ -- Bridgemarq Real Estate Services Inc. EQUITY | Nov 12, 2026, 12:30 PM UTC L Bridgemarq Real Estate 3Q EPS C$0.04 >BRE.T Bridgemarq Real Estate 3Q EPS C$0.04 >BRE.T EARNINGS | Nov 12, 2026, 12:30 PM UTC L Sagimet Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates Sagimet Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates Regi EQUITY | Nov 12, 2026, 12:30 PM UTC L Takeda Launches Narcolepsy Pill in US After DEA Clearance Takeda said its narcolepsy pill, Orzeyful, is now available in the US after a Drug Enforcement Administration decision removed the final regulatory hurdle to its rollout. EQUITY | Nov 12, 2026, 12:30 PM UTC L GENERATE BIOMEDICINES INC - Q3 EPS $-0.68 GENERATE BIOMEDICINES INC - Q3 EPS $-0.68 EARNINGS | Nov 12, 2026, 12:29 PM UTC M Sweden’s Bunge Says Recovery and Inflation Support Tighter Policy Deputy Governor Aino Bunge said Sweden’s economy is recovering broadly and inflation is expected to rise above target next year. CENTRAL_BANK | Nov 12, 2026, 12:29 PM UTC L Ukraine Seeks Details From US on Starshield Restrictions Ukraine is seeking details from the United States about restrictions on Starshield. EQUITY | Nov 12, 2026, 12:29 PM UTC L Codere Online Q3 net income more than triples to EUR 5.5 million Codere Online Q3 net income more than triples to EUR 5.5 million Codere Online’s third-quarter 2 FX | Nov 12, 2026, 12:29 PM UTC L Barclays raises Alcon target price to $80 from $70 EQUITY | Nov 12, 2026, 12:29 PM UTC L Lithium Americas Cuts FY Tariff Exposure Estimate to About $60 Million EQUITY | Nov 12, 2026, 12:29 PM UTC H *--Earnings Flash (ARCO) Arcos Dorados Posts Q3 EPS $0.15, vs. FactSet Est of $0.14 *--Earnings Flash (ARCO) Arcos Dorados Posts Q3 EPS $0.15, vs. FactSet Est of $0.14 EARNINGS | Nov 12, 2026, 12:29 PM UTC L MediWound Q3 net loss more than doubles to $5.99 million; Q3 revenue falls 34% to $3.57 million MediWound Q3 net loss more than doubles to $5.99 million; Q3 revenue falls 34% to $3.57 million EARNINGS | Nov 12, 2026, 12:29 PM UTC L Cascade Copper Confirms Historic High-Grade Drill Results at Copper Plateau Cascade Copper confirmed historic high-grade drill results at its Copper Plateau project. The report provides no grades or other drill-result details. EQUITY | Nov 12, 2026, 12:29 PM UTC L Correct: Hudbay Minerals 3Q EPS $0.34 >HBM.T Correct: Hudbay Minerals 3Q EPS $0.34 >HBM.T EARNINGS | Nov 12, 2026, 12:29 PM UTC M UK GDP Growth Prompts Higher December BOE Rate Expectations UK annual GDP expanded 2.1% in September, above the 1.9% expected by economists in a WSJ poll, lifting expectations for a BOE rate increase at its December meeting. MACRO | Nov 12, 2026, 12:29 PM UTC L Abu Dhabi Ship Building Q3 Profit 46.6 Mln Dirhams ABU DHABI SHIP BUILDING ADX:ADSB EARNINGS | Nov 12, 2026, 12:29 PM UTC M Brookfield Q3 Revenue Rises 9%, EPS Climbs EQUITY | Nov 12, 2026, 12:29 PM UTC M Aya Gold & Silver Q3-2026 net income more than doubles YoY to $35.01 million Aya Gold & Silver Q3-2026 net income more than doubles YoY to $35.01 million Aya Gold & Silver’s COMMODITIES | Nov 12, 2026, 12:29 PM UTC L Crypto-Linked Stocks Dip as MSCI Removes Strategy From Indices Crypto-linked stocks dipped after MSCI said it will remove Strategy from its indices. EQUITY | Nov 12, 2026, 12:29 PM UTC L BRIEF-Abu Dhabi Ship Building Q3 Profit 46.6 Mln Dirhams BRIEF-Abu Dhabi Ship Building Q3 Profit 46.6 Mln Dirhams Nov 12 (Reuters) - ABU DHABI SHIP BUILDING EARNINGS | Nov 12, 2026, 12:29 PM UTC L Brookfield Q3 revenue rises 9%, EPS climbs Brookfield Q3 revenue rises 9%, EPS climbs Overview Global investment firm's Q3 revenue rose 9% yr/y EARNINGS | Nov 12, 2026, 12:29 PM UTC L SOFTS-Raw sugar heads back towards 5-week low as energy prices weaken SOFTS-Raw sugar heads back towards 5-week low as energy prices weaken LONDON, Nov 12 (Reuters) - Raw EQUITY | Nov 12, 2026, 12:28 PM UTC L Correct: Hudbay Minerals 3Q Rev $765.9M >HBM.T Correct: Hudbay Minerals 3Q Rev $765.9M >HBM.T EQUITY | Nov 12, 2026, 12:28 PM UTC L SAMSONITE GROUP SA Q3 NET INCOME ATTRIBUTABLE USD 58.1 MILLION SAMSONITE GROUP SA Q3 NET INCOME ATTRIBUTABLE USD 58.1 MILLION FX | Nov 12, 2026, 12:28 PM UTC L HYPERION DEFI Q3 EPS USD 1.23 HYPERION DEFI Q3 EPS USD 1.23 EARNINGS | Nov 12, 2026, 12:28 PM UTC L ADI Global Distribution Swings to Q3 2026 Net Loss of $655 Million ADI Global Distribution Swings to Q3 2026 Net Loss of $655 Million ADI Global Distribution swung EQUITY | Nov 12, 2026, 12:28 PM UTC L GENERATE BIOMEDICINES - Q3 REVENUE $4.20 MLN GENERATE BIOMEDICINES - Q3 REVENUE $4.20 MLN EARNINGS | Nov 12, 2026, 12:28 PM UTC L Osisko Gold Names Elijah Tyshynski CFO Elijah Tyshynski will succeed Alexander Dann as CFO of Osisko Gold. EQUITY | Nov 12, 2026, 12:28 PM UTC L Bahrain's Sico Q3 Profit 544,000 Dinars SICO BAHRAIN:SICO-C EARNINGS | Nov 12, 2026, 12:28 PM UTC L BRIEF-Bahrain's Sico Q3 Profit 544,000 Dinars BRIEF-Bahrain's Sico Q3 Profit 544,000 Dinars Nov 12 (Reuters) - SICO SICO.BH: Q3 PROFIT 544,000 DIN EARNINGS | Nov 12, 2026, 12:28 PM UTC H Poste Italiane earnings below expectations at 0.46 EUR Poste Italiane (PST) released earnings per share at 0.46 EUR, compared to market expectations of 0.53 EUR. EARNINGS | Nov 12, 2026, 12:28 PM UTC L Nouveau Monde Graphite Adds Eni Representative to Board Nouveau Monde Graphite added an Eni representative to its board. EQUITY | Nov 12, 2026, 12:28 PM UTC L SAMSONITE GROUP SA Q3 SALES USD 872.7 MILLION SAMSONITE GROUP SA Q3 SALES USD 872.7 MILLION FX | Nov 12, 2026, 12:28 PM UTC M Lithium Americas targets Thacker Pass Phase 1 capex of $1.7B-$2B for FY2026 EARNINGS | Nov 12, 2026, 12:27 PM UTC M Ukraine Peace Talks Between Putin and US Envoys Start in Moscow Reuters reports that Ukraine peace talks between Putin and US envoys have started in Moscow. GEOPOLITICS | Nov 12, 2026, 12:27 PM UTC M MSCI to Remove Strategy From Global Equity Benchmarks MSCI will remove Strategy from its global equity benchmarks, including the MSCI USA index, at month-end. The report also says investors are dumping a chunk of the company’s stock. EQUITY | Nov 12, 2026, 12:27 PM UTC L CORRECTED-ARCOS DORADOS Q3 REVENUE USD 1,328 MILLION VS. IBES ESTIMATE USD 1,320 MILLION (CORRECTS AMOUNT) CORRECTED-ARCOS DORADOS Q3 REVENUE USD 1,328 MILLION VS. IBES ESTIMATE USD 1,320 MILLION (CORRECTS A EARNINGS | Nov 12, 2026, 12:27 PM UTC M SOLV Energy Q3 Revenue Rose 65% to $1.2B, Raises 2026 Guidance Q3 2026 net income was $123 million, versus $70 million a year earlier. Updated full-year guidance figures were not provided. EQUITY | Nov 12, 2026, 12:27 PM UTC L Generate Biomedicines (GENB) Reports $87.7M Q3 Net Loss; Cash Runway Into H1 2028 Generate Biomedicines reported Q3 2026 net loss of $87.7M versus $60.0M in Q3 2025. Cash, equivalents and marketable securities were $404.2M at Sept. 30, compared with $457.4M at June 30; the company expects funding into EQUITY | Nov 12, 2026, 12:27 PM UTC M TSX Futures Edge Down as AI Sentiment Weakens; Oil, Gold Fall Canadian stock futures edged lower amid weaker AI sentiment, while oil and gold also declined. EQUITY | Nov 12, 2026, 12:27 PM UTC L Petrobras Net Debt Falls 4.2% to USD 57.85 Billion in Third Quarter Petrobras Net Debt Falls 4.2% to USD 57.85 Billion in Third Quarter Petrobras’ total assets rose FX | Nov 12, 2026, 12:27 PM UTC H *--Earnings Flash (AYA) Aya Gold & Silver Posts Q3 EPS $0.22 *--Earnings Flash (AYA) Aya Gold & Silver Posts Q3 EPS $0.22 EARNINGS | Nov 12, 2026, 12:26 PM UTC L BK Technologies Q3 revenue rises on strong federal demand OverviewOutlookResult DriversCompany press release:Key DetailsAnalyst CoverageReuters Recommended ReadsFor questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feed EARNINGS | Nov 12, 2026, 12:26 PM UTC M OSISKO GOLD GROUP: Q3 2026 REVENUES $19.3MLN FROM TINTIC PROJECT TEST MINING OSISKO GOLD GROUP: Q3 2026 REVENUES $19.3MLN FROM TINTIC PROJECT TEST MINING COMMODITIES | Nov 12, 2026, 12:26 PM UTC L BK Technologies Q3 revenue rises on strong federal demand BK Technologies Q3 revenue rises on strong federal demand Overview US public safety radio maker's fi EARNINGS | Nov 12, 2026, 12:26 PM UTC L CORRECTED-BK TECHNOLOGIES CORP Q3 GROSS MARGIN 50.7% (CORRECTS AMOUNT) CORRECTED-BK TECHNOLOGIES CORP Q3 GROSS MARGIN 50.7% (CORRECTS AMOUNT) EQUITY | Nov 12, 2026, 12:26 PM UTC